Review




Structured Review

Millipore laponite bone ecm lb suspension
Schematic of the composite ink combinations used in this study
Laponite Bone Ecm Lb Suspension, supplied by Millipore, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/laponite bone ecm lb suspension/product/Millipore
Average 86 stars, based on 1 article reviews
laponite bone ecm lb suspension - by Bioz Stars, 2025-05
86/100 stars

Images

1) Product Images from "Biofabrication of nanocomposite-based scaffolds containing human bone extracellular matrix for the differentiation of skeletal stem and progenitor cells"

Article Title: Biofabrication of nanocomposite-based scaffolds containing human bone extracellular matrix for the differentiation of skeletal stem and progenitor cells

Journal: Bio-Design and Manufacturing

doi: 10.1007/s42242-023-00265-z

Schematic of the composite ink combinations used in this study
Figure Legend Snippet: Schematic of the composite ink combinations used in this study

Techniques Used:

Rheological properties of the nanoclay-based bone-ECM inks. a Viscosity over shear rate study of a series of nanoclay-based materials (a–i) in absence or (a–ii) inclusion of bone-ECM. b LAB gel over rheometer plates showing viscoelastic behavior. (c) Viscosity comparison at a fixed shear rate (10 s –1 ). d Storage and loss moduli of nanoclay-based materials (d–i, d–iii) without and (d–ii, d–iv) when blended with bone-ECM. Statistical significance was assessed by one-way ANOVA. Data are presented as mean±standard deviation, n =3, ∗∗∗∗ p <0.0001. ECM: extracellular matrix; LAB: Laponite-alginate-bone-ECM; ANOVA: analysis of variance
Figure Legend Snippet: Rheological properties of the nanoclay-based bone-ECM inks. a Viscosity over shear rate study of a series of nanoclay-based materials (a–i) in absence or (a–ii) inclusion of bone-ECM. b LAB gel over rheometer plates showing viscoelastic behavior. (c) Viscosity comparison at a fixed shear rate (10 s –1 ). d Storage and loss moduli of nanoclay-based materials (d–i, d–iii) without and (d–ii, d–iv) when blended with bone-ECM. Statistical significance was assessed by one-way ANOVA. Data are presented as mean±standard deviation, n =3, ∗∗∗∗ p <0.0001. ECM: extracellular matrix; LAB: Laponite-alginate-bone-ECM; ANOVA: analysis of variance

Techniques Used: Viscosity, Shear, Comparison, Standard Deviation

Printing fidelity of nanocomposite bone-ECM inks. a Filament fusion test was carried out with (a–i) AB and (a–ii) LAB inks. b Measurements of the filament fusion tests performed with (b–i) 3% and (b–ii) 4% LAP composite inks. c Micrographs of scaffolds printed with (c–i) 3% and (c–ii) 4% LAP-based inks. Scale bar: 1 mm. AB: alginate-bone-ECM; LAB: Laponite-alginate-bone-ECM; LAP: Laponite; fs: fused segment length; ft: filament thickness; fd: filament distance
Figure Legend Snippet: Printing fidelity of nanocomposite bone-ECM inks. a Filament fusion test was carried out with (a–i) AB and (a–ii) LAB inks. b Measurements of the filament fusion tests performed with (b–i) 3% and (b–ii) 4% LAP composite inks. c Micrographs of scaffolds printed with (c–i) 3% and (c–ii) 4% LAP-based inks. Scale bar: 1 mm. AB: alginate-bone-ECM; LAB: Laponite-alginate-bone-ECM; LAP: Laponite; fs: fused segment length; ft: filament thickness; fd: filament distance

Techniques Used:

HBMSC viability and proliferation post-printing. Live/dead assay was performed on 3D-printed a – c AB and d – f LAB scaffolds at Days 1, 7, and 21. g Cell viability and h density quantification following ImageJ analysis. j – m ALP staining of 3D bioprinted scaffolds following cultivation in basal (AB, j; LAB, l) and osteogenic (AB, k; LAB, m) media conditioning complete with acellular control (insets). n ALP intensity and o area coverage percentage. Scale bars: a – f 100 µm, j – m 50 µm (samples), 250 µm (acellular controls). Statistical significance was determined using two-way ANOVA. Data are presented as mean±standard deviation, n =3, ∗∗∗∗ p <0.0001. HBMSC: human bone marrow stromal cell; AB: alginate-bone-ECM; LAB: Laponite-alginate-bone-ECM; ALP: alkaline phosphatase; ANOVA: analysis of variance; O: osteogenic; B: basal
Figure Legend Snippet: HBMSC viability and proliferation post-printing. Live/dead assay was performed on 3D-printed a – c AB and d – f LAB scaffolds at Days 1, 7, and 21. g Cell viability and h density quantification following ImageJ analysis. j – m ALP staining of 3D bioprinted scaffolds following cultivation in basal (AB, j; LAB, l) and osteogenic (AB, k; LAB, m) media conditioning complete with acellular control (insets). n ALP intensity and o area coverage percentage. Scale bars: a – f 100 µm, j – m 50 µm (samples), 250 µm (acellular controls). Statistical significance was determined using two-way ANOVA. Data are presented as mean±standard deviation, n =3, ∗∗∗∗ p <0.0001. HBMSC: human bone marrow stromal cell; AB: alginate-bone-ECM; LAB: Laponite-alginate-bone-ECM; ALP: alkaline phosphatase; ANOVA: analysis of variance; O: osteogenic; B: basal

Techniques Used: Live Dead Assay, Staining, Standard Deviation

Nanoclay-based inks support sustained release of VEGF in the CAM model. Macrographs during a sample implantation and b retrieval: (i) empty, (ii) AB, (iii) LAB, and VEGF-loaded (iv) AB and (v) LAB 3D-printed scaffolds. c Chalkley score of vascularized samples and controls. d – g Histological micrographs of samples stained for (i, ii) Goldner’s Trichrome and (iii, iv) Alcian Blue & Sirius Red. Statistical significance was assessed using one-way ANOVA. Data are presented as mean±standard deviation, n =4, * p <0.05, ** p <0.01, *** p <0.001, **** p <0.0001. Scale bars: a , b 10 mm, d – g 100 µm. VEGF: vascular endothelial growth factor; CAM: chick chorioallantoic membrane; AB: alginate-bone-ECM; LAB: Laponite-alginate-bone-ECM; ANOVA: analysis of variance
Figure Legend Snippet: Nanoclay-based inks support sustained release of VEGF in the CAM model. Macrographs during a sample implantation and b retrieval: (i) empty, (ii) AB, (iii) LAB, and VEGF-loaded (iv) AB and (v) LAB 3D-printed scaffolds. c Chalkley score of vascularized samples and controls. d – g Histological micrographs of samples stained for (i, ii) Goldner’s Trichrome and (iii, iv) Alcian Blue & Sirius Red. Statistical significance was assessed using one-way ANOVA. Data are presented as mean±standard deviation, n =4, * p <0.05, ** p <0.01, *** p <0.001, **** p <0.0001. Scale bars: a , b 10 mm, d – g 100 µm. VEGF: vascular endothelial growth factor; CAM: chick chorioallantoic membrane; AB: alginate-bone-ECM; LAB: Laponite-alginate-bone-ECM; ANOVA: analysis of variance

Techniques Used: Staining, Standard Deviation, Membrane

Nanocomposite bone-ECM scaffolds support mineralization ex vivo. a Macro- and micro-graphs of empty control. Implanted and explanted b LAP-free and c LAP-loaded 3D (i) material (drug- and cell-free) control, (ii) BMP-2 loaded, (iii) cell-loaded, and (iv) BMP-2 and cell loaded scaffolds. d Chalkley score of implanted samples and control after 7 d of culture. e Quantitative analysis of afferent vascular supply to implanted scaffolds before extraction. f Micro-CT analysis of implanted scaffolds following 7 d of incubation in a CAM model. Scale bars: a – c 10 mm. Statistical significance was assessed by one-way ANOVA. Data are presented as mean±standard deviation, n =4, * p <0.05, ** p <0.01, *** p <0.001, **** p <0.0001. LAP: Laponite; 3D: three-dimensional; BMP-2: bone morphogenetic protein-2; micro-CT: microcomputed tomography; CAM: chick chorioallantoic membrane; ANOVA: analysis of variance; HBMSCs: human bone marrow stromal cells
Figure Legend Snippet: Nanocomposite bone-ECM scaffolds support mineralization ex vivo. a Macro- and micro-graphs of empty control. Implanted and explanted b LAP-free and c LAP-loaded 3D (i) material (drug- and cell-free) control, (ii) BMP-2 loaded, (iii) cell-loaded, and (iv) BMP-2 and cell loaded scaffolds. d Chalkley score of implanted samples and control after 7 d of culture. e Quantitative analysis of afferent vascular supply to implanted scaffolds before extraction. f Micro-CT analysis of implanted scaffolds following 7 d of incubation in a CAM model. Scale bars: a – c 10 mm. Statistical significance was assessed by one-way ANOVA. Data are presented as mean±standard deviation, n =4, * p <0.05, ** p <0.01, *** p <0.001, **** p <0.0001. LAP: Laponite; 3D: three-dimensional; BMP-2: bone morphogenetic protein-2; micro-CT: microcomputed tomography; CAM: chick chorioallantoic membrane; ANOVA: analysis of variance; HBMSCs: human bone marrow stromal cells

Techniques Used: Ex Vivo, Extraction, Micro-CT, Incubation, Standard Deviation, Tomography, Membrane

CAM implantation of 3D-printed scaffolds containing BMP-2 and HBMSCs. a – d LAP-free and e – h LAP-loaded groups are stained for (i, ii) Goldner’s Trichrome, (iii, iv) Alcian Blue & Sirius Red, and (v, vi) von Kossa. Scale bars: 100 µm. CAM: chick chorioallantoic membrane; 3D: three-dimensional; BMP-2: bone morphogenetic protein-2; HBMSCs: human bone marrow stromal cells; LAP: Laponite
Figure Legend Snippet: CAM implantation of 3D-printed scaffolds containing BMP-2 and HBMSCs. a – d LAP-free and e – h LAP-loaded groups are stained for (i, ii) Goldner’s Trichrome, (iii, iv) Alcian Blue & Sirius Red, and (v, vi) von Kossa. Scale bars: 100 µm. CAM: chick chorioallantoic membrane; 3D: three-dimensional; BMP-2: bone morphogenetic protein-2; HBMSCs: human bone marrow stromal cells; LAP: Laponite

Techniques Used: Staining, Membrane



Similar Products

86
Millipore laponite bone ecm lb suspension
Schematic of the composite ink combinations used in this study
Laponite Bone Ecm Lb Suspension, supplied by Millipore, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/laponite bone ecm lb suspension/product/Millipore
Average 86 stars, based on 1 article reviews
laponite bone ecm lb suspension - by Bioz Stars, 2025-05
86/100 stars
  Buy from Supplier

Image Search Results


Schematic of the composite ink combinations used in this study

Journal: Bio-Design and Manufacturing

Article Title: Biofabrication of nanocomposite-based scaffolds containing human bone extracellular matrix for the differentiation of skeletal stem and progenitor cells

doi: 10.1007/s42242-023-00265-z

Figure Lengend Snippet: Schematic of the composite ink combinations used in this study

Article Snippet: Following 2 h stirring at room temperature, alginate (A, alginic acid sodium salt from brown algae, Sigma, UK) was added to the Laponite-bone-ECM (LB) suspension and homogenized with a spatula for 8–10 min to allow alginate inclusion.

Techniques:

Rheological properties of the nanoclay-based bone-ECM inks. a Viscosity over shear rate study of a series of nanoclay-based materials (a–i) in absence or (a–ii) inclusion of bone-ECM. b LAB gel over rheometer plates showing viscoelastic behavior. (c) Viscosity comparison at a fixed shear rate (10 s –1 ). d Storage and loss moduli of nanoclay-based materials (d–i, d–iii) without and (d–ii, d–iv) when blended with bone-ECM. Statistical significance was assessed by one-way ANOVA. Data are presented as mean±standard deviation, n =3, ∗∗∗∗ p <0.0001. ECM: extracellular matrix; LAB: Laponite-alginate-bone-ECM; ANOVA: analysis of variance

Journal: Bio-Design and Manufacturing

Article Title: Biofabrication of nanocomposite-based scaffolds containing human bone extracellular matrix for the differentiation of skeletal stem and progenitor cells

doi: 10.1007/s42242-023-00265-z

Figure Lengend Snippet: Rheological properties of the nanoclay-based bone-ECM inks. a Viscosity over shear rate study of a series of nanoclay-based materials (a–i) in absence or (a–ii) inclusion of bone-ECM. b LAB gel over rheometer plates showing viscoelastic behavior. (c) Viscosity comparison at a fixed shear rate (10 s –1 ). d Storage and loss moduli of nanoclay-based materials (d–i, d–iii) without and (d–ii, d–iv) when blended with bone-ECM. Statistical significance was assessed by one-way ANOVA. Data are presented as mean±standard deviation, n =3, ∗∗∗∗ p <0.0001. ECM: extracellular matrix; LAB: Laponite-alginate-bone-ECM; ANOVA: analysis of variance

Article Snippet: Following 2 h stirring at room temperature, alginate (A, alginic acid sodium salt from brown algae, Sigma, UK) was added to the Laponite-bone-ECM (LB) suspension and homogenized with a spatula for 8–10 min to allow alginate inclusion.

Techniques: Viscosity, Shear, Comparison, Standard Deviation

Printing fidelity of nanocomposite bone-ECM inks. a Filament fusion test was carried out with (a–i) AB and (a–ii) LAB inks. b Measurements of the filament fusion tests performed with (b–i) 3% and (b–ii) 4% LAP composite inks. c Micrographs of scaffolds printed with (c–i) 3% and (c–ii) 4% LAP-based inks. Scale bar: 1 mm. AB: alginate-bone-ECM; LAB: Laponite-alginate-bone-ECM; LAP: Laponite; fs: fused segment length; ft: filament thickness; fd: filament distance

Journal: Bio-Design and Manufacturing

Article Title: Biofabrication of nanocomposite-based scaffolds containing human bone extracellular matrix for the differentiation of skeletal stem and progenitor cells

doi: 10.1007/s42242-023-00265-z

Figure Lengend Snippet: Printing fidelity of nanocomposite bone-ECM inks. a Filament fusion test was carried out with (a–i) AB and (a–ii) LAB inks. b Measurements of the filament fusion tests performed with (b–i) 3% and (b–ii) 4% LAP composite inks. c Micrographs of scaffolds printed with (c–i) 3% and (c–ii) 4% LAP-based inks. Scale bar: 1 mm. AB: alginate-bone-ECM; LAB: Laponite-alginate-bone-ECM; LAP: Laponite; fs: fused segment length; ft: filament thickness; fd: filament distance

Article Snippet: Following 2 h stirring at room temperature, alginate (A, alginic acid sodium salt from brown algae, Sigma, UK) was added to the Laponite-bone-ECM (LB) suspension and homogenized with a spatula for 8–10 min to allow alginate inclusion.

Techniques:

HBMSC viability and proliferation post-printing. Live/dead assay was performed on 3D-printed a – c AB and d – f LAB scaffolds at Days 1, 7, and 21. g Cell viability and h density quantification following ImageJ analysis. j – m ALP staining of 3D bioprinted scaffolds following cultivation in basal (AB, j; LAB, l) and osteogenic (AB, k; LAB, m) media conditioning complete with acellular control (insets). n ALP intensity and o area coverage percentage. Scale bars: a – f 100 µm, j – m 50 µm (samples), 250 µm (acellular controls). Statistical significance was determined using two-way ANOVA. Data are presented as mean±standard deviation, n =3, ∗∗∗∗ p <0.0001. HBMSC: human bone marrow stromal cell; AB: alginate-bone-ECM; LAB: Laponite-alginate-bone-ECM; ALP: alkaline phosphatase; ANOVA: analysis of variance; O: osteogenic; B: basal

Journal: Bio-Design and Manufacturing

Article Title: Biofabrication of nanocomposite-based scaffolds containing human bone extracellular matrix for the differentiation of skeletal stem and progenitor cells

doi: 10.1007/s42242-023-00265-z

Figure Lengend Snippet: HBMSC viability and proliferation post-printing. Live/dead assay was performed on 3D-printed a – c AB and d – f LAB scaffolds at Days 1, 7, and 21. g Cell viability and h density quantification following ImageJ analysis. j – m ALP staining of 3D bioprinted scaffolds following cultivation in basal (AB, j; LAB, l) and osteogenic (AB, k; LAB, m) media conditioning complete with acellular control (insets). n ALP intensity and o area coverage percentage. Scale bars: a – f 100 µm, j – m 50 µm (samples), 250 µm (acellular controls). Statistical significance was determined using two-way ANOVA. Data are presented as mean±standard deviation, n =3, ∗∗∗∗ p <0.0001. HBMSC: human bone marrow stromal cell; AB: alginate-bone-ECM; LAB: Laponite-alginate-bone-ECM; ALP: alkaline phosphatase; ANOVA: analysis of variance; O: osteogenic; B: basal

Article Snippet: Following 2 h stirring at room temperature, alginate (A, alginic acid sodium salt from brown algae, Sigma, UK) was added to the Laponite-bone-ECM (LB) suspension and homogenized with a spatula for 8–10 min to allow alginate inclusion.

Techniques: Live Dead Assay, Staining, Standard Deviation

Nanoclay-based inks support sustained release of VEGF in the CAM model. Macrographs during a sample implantation and b retrieval: (i) empty, (ii) AB, (iii) LAB, and VEGF-loaded (iv) AB and (v) LAB 3D-printed scaffolds. c Chalkley score of vascularized samples and controls. d – g Histological micrographs of samples stained for (i, ii) Goldner’s Trichrome and (iii, iv) Alcian Blue & Sirius Red. Statistical significance was assessed using one-way ANOVA. Data are presented as mean±standard deviation, n =4, * p <0.05, ** p <0.01, *** p <0.001, **** p <0.0001. Scale bars: a , b 10 mm, d – g 100 µm. VEGF: vascular endothelial growth factor; CAM: chick chorioallantoic membrane; AB: alginate-bone-ECM; LAB: Laponite-alginate-bone-ECM; ANOVA: analysis of variance

Journal: Bio-Design and Manufacturing

Article Title: Biofabrication of nanocomposite-based scaffolds containing human bone extracellular matrix for the differentiation of skeletal stem and progenitor cells

doi: 10.1007/s42242-023-00265-z

Figure Lengend Snippet: Nanoclay-based inks support sustained release of VEGF in the CAM model. Macrographs during a sample implantation and b retrieval: (i) empty, (ii) AB, (iii) LAB, and VEGF-loaded (iv) AB and (v) LAB 3D-printed scaffolds. c Chalkley score of vascularized samples and controls. d – g Histological micrographs of samples stained for (i, ii) Goldner’s Trichrome and (iii, iv) Alcian Blue & Sirius Red. Statistical significance was assessed using one-way ANOVA. Data are presented as mean±standard deviation, n =4, * p <0.05, ** p <0.01, *** p <0.001, **** p <0.0001. Scale bars: a , b 10 mm, d – g 100 µm. VEGF: vascular endothelial growth factor; CAM: chick chorioallantoic membrane; AB: alginate-bone-ECM; LAB: Laponite-alginate-bone-ECM; ANOVA: analysis of variance

Article Snippet: Following 2 h stirring at room temperature, alginate (A, alginic acid sodium salt from brown algae, Sigma, UK) was added to the Laponite-bone-ECM (LB) suspension and homogenized with a spatula for 8–10 min to allow alginate inclusion.

Techniques: Staining, Standard Deviation, Membrane

Nanocomposite bone-ECM scaffolds support mineralization ex vivo. a Macro- and micro-graphs of empty control. Implanted and explanted b LAP-free and c LAP-loaded 3D (i) material (drug- and cell-free) control, (ii) BMP-2 loaded, (iii) cell-loaded, and (iv) BMP-2 and cell loaded scaffolds. d Chalkley score of implanted samples and control after 7 d of culture. e Quantitative analysis of afferent vascular supply to implanted scaffolds before extraction. f Micro-CT analysis of implanted scaffolds following 7 d of incubation in a CAM model. Scale bars: a – c 10 mm. Statistical significance was assessed by one-way ANOVA. Data are presented as mean±standard deviation, n =4, * p <0.05, ** p <0.01, *** p <0.001, **** p <0.0001. LAP: Laponite; 3D: three-dimensional; BMP-2: bone morphogenetic protein-2; micro-CT: microcomputed tomography; CAM: chick chorioallantoic membrane; ANOVA: analysis of variance; HBMSCs: human bone marrow stromal cells

Journal: Bio-Design and Manufacturing

Article Title: Biofabrication of nanocomposite-based scaffolds containing human bone extracellular matrix for the differentiation of skeletal stem and progenitor cells

doi: 10.1007/s42242-023-00265-z

Figure Lengend Snippet: Nanocomposite bone-ECM scaffolds support mineralization ex vivo. a Macro- and micro-graphs of empty control. Implanted and explanted b LAP-free and c LAP-loaded 3D (i) material (drug- and cell-free) control, (ii) BMP-2 loaded, (iii) cell-loaded, and (iv) BMP-2 and cell loaded scaffolds. d Chalkley score of implanted samples and control after 7 d of culture. e Quantitative analysis of afferent vascular supply to implanted scaffolds before extraction. f Micro-CT analysis of implanted scaffolds following 7 d of incubation in a CAM model. Scale bars: a – c 10 mm. Statistical significance was assessed by one-way ANOVA. Data are presented as mean±standard deviation, n =4, * p <0.05, ** p <0.01, *** p <0.001, **** p <0.0001. LAP: Laponite; 3D: three-dimensional; BMP-2: bone morphogenetic protein-2; micro-CT: microcomputed tomography; CAM: chick chorioallantoic membrane; ANOVA: analysis of variance; HBMSCs: human bone marrow stromal cells

Article Snippet: Following 2 h stirring at room temperature, alginate (A, alginic acid sodium salt from brown algae, Sigma, UK) was added to the Laponite-bone-ECM (LB) suspension and homogenized with a spatula for 8–10 min to allow alginate inclusion.

Techniques: Ex Vivo, Extraction, Micro-CT, Incubation, Standard Deviation, Tomography, Membrane

CAM implantation of 3D-printed scaffolds containing BMP-2 and HBMSCs. a – d LAP-free and e – h LAP-loaded groups are stained for (i, ii) Goldner’s Trichrome, (iii, iv) Alcian Blue & Sirius Red, and (v, vi) von Kossa. Scale bars: 100 µm. CAM: chick chorioallantoic membrane; 3D: three-dimensional; BMP-2: bone morphogenetic protein-2; HBMSCs: human bone marrow stromal cells; LAP: Laponite

Journal: Bio-Design and Manufacturing

Article Title: Biofabrication of nanocomposite-based scaffolds containing human bone extracellular matrix for the differentiation of skeletal stem and progenitor cells

doi: 10.1007/s42242-023-00265-z

Figure Lengend Snippet: CAM implantation of 3D-printed scaffolds containing BMP-2 and HBMSCs. a – d LAP-free and e – h LAP-loaded groups are stained for (i, ii) Goldner’s Trichrome, (iii, iv) Alcian Blue & Sirius Red, and (v, vi) von Kossa. Scale bars: 100 µm. CAM: chick chorioallantoic membrane; 3D: three-dimensional; BMP-2: bone morphogenetic protein-2; HBMSCs: human bone marrow stromal cells; LAP: Laponite

Article Snippet: Following 2 h stirring at room temperature, alginate (A, alginic acid sodium salt from brown algae, Sigma, UK) was added to the Laponite-bone-ECM (LB) suspension and homogenized with a spatula for 8–10 min to allow alginate inclusion.

Techniques: Staining, Membrane